Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 10,485 | 15,143 | 14,583 | 451 | -52,881 |
| Depreciation Amortization | 92 | 72 | 49 | 25 | 111 |
| Other Working Capital | -19,088 | -19,679 | -18,684 | -1,161 | -6,907 |
| Other Operating Activity | 2,995 | 2,650 | 2,028 | 639 | 20,944 |
| Operating Cash Flow | $-5,516 | $-1,814 | $-2,024 | $-46 | $-38,733 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -15,250 | -1 | 2,299 | -1 | 10,167 |
| PPE Investments | -4 | -4 | -4 | N/A | -146 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -1 |
| Sale Of Investment | 5,557 | 2,350 | N/A | N/A | 22,569 |
| Investing Cash Flow | $-9,697 | $2,345 | $2,295 | $-1 | $32,589 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 18,456 | 20,014 | N/A | N/A | 222 |
| Other Financing Activity | 0 | -6 | 0 | 0 | 0 |
| Financing Cash Flow | $18,456 | $20,008 | $N/A | $N/A | $222 |
| Beginning Cash Position | 13,143 | 13,143 | 13,143 | 13,143 | 19,065 |
| End Cash Position | 16,386 | 33,682 | 13,414 | 13,096 | 13,143 |
| Net Cash Flow | $3,243 | $20,539 | $271 | $-47 | $-5,922 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,516 | -1,814 | -2,024 | -46 | -38,733 |
| Capital Expenditure | -4 | -4 | -4 | N/A | -146 |
| Free Cash Flow | -5,520 | -1,818 | -2,028 | -46 | -38,879 |